We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CareFusion to Acquire Brazilian Respiratory Company

By HospiMedica International staff writers
Posted on 16 Oct 2012
CareFusion (San Diego, CA, USA), a global medical technology company, has agreed to acquire Intermed Equipamento Medico Hospitalar (Intermed; Sao Paulo, Brazil), a privately held leading respiratory technologies company. More...
Financial terms were not disclosed.

Intermed designs, manufactures, and markets a variety of ventilators and respiratory care devices for the full spectrum of infant, pediatric, and adult patients used in hospitals in Brazil and across Latin America. The acquisition is part of CareFusion's strategy to accelerate long-term growth, and it will help increase the momentum of the globalization strategy by leveraging existing distribution channels and offering additional CareFusion products. The Intermed product platform, specifically designed to address the unique needs and cost structure of Latin America and other emerging markets, is a key factor in this process.

“The acquisition of Intermed complements our global respiratory product platform and advances our strategy to expand outside of the US through investments that build scale and local capabilities in high-value markets,” said Kieran Gallahue, chairman and CEO of CareFusion. “Intermed brings a strong distributor network, local manufacturing capabilities and a new product portfolio that we believe can serve as a base for CareFusion to continue our global expansion efforts in Latin America.”

“For more than 30 years, Intermed has supported the evolving health care needs of Brazil through high-quality medical devices, and we are extremely proud of the company we have built,” said Milton Rubens Salles, founder of Intermed. “CareFusion shares our values and passion to serve hospitals' and patients' respiratory needs and create additional opportunities for our people and products to continue to grow through investments in research and development and global expansion.”

CareFusion is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including the Alaris infusion pumps, the Pyxis automated dispensing and patient identification systems, the AVEA, AirLife, and LTV series of ventilation and respiratory products, ChloraPrep products, MedMined services for data mining surveillance, V. Mueller surgical instruments, and an extensive line of products that support interventional medicine.

Related Links:

CareFusion
Intermed Equipamento Medico Hospitalar



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.